AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Plunge Analysis
/
Liminatus Pharma Inc.
/
2026-05-22
▼ PLUNGE
Liminatus Pharma Inc.
-32.0%
LIMN
NASDAQ
Healthcare
2026-05-22
0.167
Close
0.246
Prev Close
-31.99%
Change
0.1x
Vol Ratio
Why It Plunged
No related news available.
Related News
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit
Gurufocus
2026-04-19
InMed Pharmaceuticals Reprices Investment Options to Attract Capital
Tipranks
2026-04-27
Apimeds Pharmaceuticals And Lōkahi Therapeutics Secure FDA Type C Meeting To Discuss LT-100, Non-Opioid Biologic Candidate Being Developed For Osteoarthritis Treatment - Apimeds Pharmaceuticals (AMEX:APUS)
Benzinga
2026-02-11
India's Alembic Pharma quarterly profit rises on strong U.S. generics demand
Reuters
2026-05-15
InMed and Mentari announce all-stock merger deal (INM:NASDAQ)
Seekingalpha
2026-05-19
Technical Analysis
Signals
MACD Bearish
Below SMA20
Key Indicators
41.99
RSI (14)
0.20
SMA 20
0.17
Bollinger Lower
0.23
Bollinger Upper
0.20
Bollinger Mid
-0.00
MACD
-0.00
MACD Signal
-0.00
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Liminatus Pharma Inc. Surged +-32.0% on 2026-05-22 — Analysis | Alpha Lenz